Roche, Mayo Clinic to Release 1-Hour PCR-Based Anthrax Diagnostic | GenomeWeb

NEW YORK, Nov. 5 - Roche Holding is about to release a DNA-based test it developed with the Mayo Clinic that can help researchers identify anthrax faster than other products, the company said on Monday.

"The new test can identify the presence of anthrax in less than one hour instead of days," the Swiss pharmaceutical company said in a statement.

Roche will provide the product beginning next week at no charge to roughly 24 laboratories in the United States that are equipped with its LightCycler PCR technology, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.